Avantax Planning Partners’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,716	Closed	-$54.3K	–	464
2025 Q1	$54.3K	Buy	3,716 +2,423	+187%	+$35.4K	﹤0.01%	426
2024 Q4	$155K	Buy	1,293 +612	+90%	+$73.4K	0.01%	419
2024 Q3	$127K	Buy	681 +641	+1,603%	+$120K	﹤0.01%	427
2024 Q2	$23.9K	Buy	+40	New	+$23.9K	﹤0.01%	467